— Ticker · NYQ —
LLY · Eli Lilly and Company
Healthcare · Drug Manufacturers - General
LLY
$1064.74
▲ +5.95%
7-day move
7-day move
day$1060.41 → $1081.9952-wk$623.78 → $1133.95avg vol3.1M / 3Mcap$949.5B
Plate I.
The Past Year, in One Line
The Valuation
| P/E (forward) | 23.9 |
| P/E (trailing) | 37.9 |
| EPS (forward) | $44.47 |
| EPS (trailing) | $28.12 |
| PEG | 1.43 |
| Dividend | 65.00% |
The Risk
| Beta | 0.48 |
| Short % float | 0.88% |
| Float | 889.3M |
| Shares out | 891.7M |
| Avg vol (3M) | 3.1M |
| 52w range | $623.78 → $1133.95 |
The Analyst Tape
strong buybuyholdunderperformsell
$1211.03
avg 12-mo target
+13.7%
vs. last · 29 analysts
At a Glance
$949.5B
market cap (USD)
exchangeNYQ
sectorHealthcare
industryDrug Manufacturers - General
market cap$949.5B
websitelilly.com
The Briefs
live, polled every 60 seconds · Alpaca / Benzinga
No recent headlines for LLY in the last 7 days.
Word on the Street
StockTwits public feed · self-tagged bull/bear
No recent StockTwits posts for LLY.
Indicators That Mention LLY
1 of our 596 catalog map to LLY
SP-3394
LLY TRI Chemical Releases
Annual chemical releases from Eli Lilly US plants. Pharma production (incl. GLP-1).
50%
50%
50%
50%
50%
50%
◐Too new to retest
r=0.00
Standard Poorly Disclaimer
We tested 297 indicators against four horizons. By chance alone, ~59 of these correlations should look "significant." Walk-forward out-of-sample is the only thing we trust. This one too new to retest.Other Players in the Pipeline
Healthcare · by market cap · 7-day move